Sign in
Taking people in United StatesNo phase

Tests a lifestyle program tailored to individual profiles for obesity

Tests a tailored lifestyle program for weight loss in adults with obesity.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
Status
Recruiting
People taking part
228 people, planned
Started
22 Jan 2025
Expected to end
Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Standard Lifestyle Intervention (SLI) program
  • Phenotype-tailored Lifestyle Intervention (PLI) program
Record updated
11 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men and women aged 18 to 65 who have obesity (BMI over 30 kg/m2).

Age
18 to 65 years
Sex
Men and women
Disease stage
Obesity, with a BMI over 30 kg/m2
Earlier treatment
People who had bariatric surgery or bariatric endoscopy, who currently use AOMs, or who used medications affecting weight, energy intake or energy expenditure in the last 6 months cannot join.

Main reasons for not taking part

  • Weight change greater than 3% in the previous 3 months
  • History of bariatric surgery or bariatric endoscopy
  • Untreated psychiatric disorders, including binge eating disorders and bulimia
  • History of type 1 diabetes mellitus or uncontrolled medical conditions, such as uncontrolled hypertension
  • Pregnant women or women who plan to become pregnant

The registry criteria, word for word

Show all 11 criteriaShow less

Other criteria

  • Inclusion:
  • men or women between 18 to 65 years with obesity (BMI>30kg/m2); Exclusion:
  • weight change greater than 3% in the previous 3 months
  • history of bariatric surgery and bariatric endoscopy
  • untreated psychiatric disorders including binge eating disorders and bulimia
  • current use of AOMs
  • history of use of medications affecting weight or energy intake or energy expenditure in the last 6 months
  • history of type 1 diabetes mellitus or uncontrolled medical conditions (e.g., uncontrolled hypertension)
  • women who are pregnant or plan to become pregnant,
  • any condition that limits their participation in the study
  • Principal Investigator discretion

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Mayo ClinicRochester, United StatesContact: Megan SchaeferTaking people

About the trial

What the trial wants to find out

The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.

The 2 groups in the trial

  • Standard Lifestyle Intervention (SLI) programExisting treatment, for comparison
  • Phenotype-tailored Lifestyle Intervention (PLI) programTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
Plain-language title
Tests a lifestyle program tailored to individual profiles for obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06770049, who can take part
Record updated
11 June 2026